CX157
CX157[edit | edit source]
CX157 is a pharmaceutical drug that acts as a reversible inhibitor of monoamine oxidase A (RIMA). It is primarily researched for its potential use in the treatment of depression and other mood disorders.
Mechanism of Action[edit | edit source]
CX157 functions by selectively inhibiting the monoamine oxidase A (MAO-A) enzyme. This enzyme is responsible for the breakdown of monoamines such as serotonin, norepinephrine, and dopamine. By inhibiting MAO-A, CX157 increases the availability of these neurotransmitters in the synaptic cleft, which can enhance mood and alleviate symptoms of depression.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of CX157 involves its absorption, distribution, metabolism, and excretion. CX157 is known for its rapid absorption and ability to cross the blood-brain barrier, allowing it to exert its effects on central nervous system neurotransmitters. The drug is metabolized primarily in the liver and excreted through the renal system.
Clinical Applications[edit | edit source]
CX157 has been investigated in clinical trials for its efficacy in treating major depressive disorder (MDD). Its reversible inhibition of MAO-A offers an advantage over traditional monoamine oxidase inhibitors (MAOIs), as it reduces the risk of tyramine-induced hypertensive crisis, a common side effect associated with non-selective and irreversible MAOIs.
Side Effects[edit | edit source]
Common side effects of CX157 may include nausea, headache, and insomnia. Due to its selective action, it has a more favorable side effect profile compared to older MAOIs. However, patients are still advised to avoid certain foods and medications that can interact with MAO-A inhibitors.
Research and Development[edit | edit source]
Research on CX157 is ongoing, with studies focusing on its long-term efficacy and safety in treating mood disorders. The development of CX157 is part of a broader effort to create more effective and safer antidepressant medications.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
